BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29655803)

  • 1. Role of MSC-derived galectin 3 in the AML microenvironment.
    Ruvolo PP; Ruvolo VR; Burks JK; Qiu Y; Wang RY; Shpall EJ; Mirandola L; Hail N; Zeng Z; McQueen T; Daver N; Post SM; Chiriva-Internati M; Kornblau SM; Andreeff M
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):959-969. PubMed ID: 29655803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectins as regulators of cell survival in the leukemia niche.
    Ruvolo PP
    Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
    Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
    EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.
    Kornblau SM; Ruvolo PP; Wang RY; Battula VL; Shpall EJ; Ruvolo VR; McQueen T; Qui Y; Zeng Z; Pierce S; Jacamo R; Yoo SY; Le PM; Sun J; Hail N; Konopleva M; Andreeff M
    Haematologica; 2018 May; 103(5):810-821. PubMed ID: 29545342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
    Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
    Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
    Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
    Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
    Ruvolo PP; Ruvolo VR; Benton CB; AlRawi A; Burks JK; Schober W; Rolke J; Tidmarsh G; Hail N; Davis RE; Andreeff M
    Biochim Biophys Acta; 2016 Apr; 1863(4):562-71. PubMed ID: 26704388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
    Schelker RC; Kratzer A; Müller G; Brochhausen C; Hart C; Stempfl T; Heudobler D; Moehle C; Herr W; Iberl S; Grassinger J
    Hematology; 2021 Dec; 26(1):565-576. PubMed ID: 34384344
    [No Abstract]   [Full Text] [Related]  

  • 9. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
    Hu K; Gu Y; Lou L; Liu L; Hu Y; Wang B; Luo Y; Shi J; Yu X; Huang H
    J Hematol Oncol; 2015 Jan; 8():1. PubMed ID: 25622682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia.
    Cheng CL; Hou HA; Lee MC; Liu CY; Jhuang JY; Lai YJ; Lin CW; Chen HY; Liu FT; Chou WC; Chen CY; Tang JL; Yao M; Huang SY; Ko BS; Wu SJ; Tsay W; Tien HF
    Blood; 2013 Apr; 121(16):3172-80. PubMed ID: 23449638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
    Corradi G; Bassani B; Simonetti G; Sangaletti S; Vadakekolathu J; Fontana MC; Pazzaglia M; Gulino A; Tripodo C; Cristiano G; Bandini L; Ottaviani E; Ocadlikova D; Piccioli M; Martinelli G; Colombo MP; Rutella S; Cavo M; Ciciarello M; Curti A
    Clin Cancer Res; 2022 Jul; 28(14):3141-3155. PubMed ID: 35349670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of c-Myc in mesenchymal stromal cell-mediated drug resistance in acute leukemia cells].
    Xia B; Guo Q; Zhao WP; Guo SQ; Tian C; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1746-9. PubMed ID: 24124686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
    Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Acute Myeloid Leukemia Cells on the Proliferation and Apoptosis of Bone Marrow-Derived Mesenchymal Stromal Cells].
    Chen ZH; Zheng YX; Si JQ; Yuan T; Zhang ZR; Tian C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):430-434. PubMed ID: 35395975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes.
    Kargar-Sichani Y; Mohammadi MH; Amiri V; Barzegar M; Keshavarz A; Bashash D; Farsani MA
    Arch Med Res; 2023 Feb; 54(2):95-104. PubMed ID: 36717322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.